Harnessing Exosomes for Diabetes Care Solutions
Welcome to our article series on innovative diabetes care solutions. In today’s installment, we will explore the exciting potential of stem cell-derived exosomes in diabetes management. These tiny vesicles, derived from stem cells, offer a new avenue for enhanced healing and improved outcomes for patients with diabetes. Stem cell-derived exosomes have emerged as a promising […]
Unlocking Burn Healing: Aegle’s Breakthrough Therapy
Aegle Therapeutics Corp., a clinical-stage biotechnology company, has announced the initiation of its Phase 1/2a clinical trial, marking the dosing of its first patient. The trial will focus on the administration of AGLE-102™, a novel therapy designed to treat severe second-degree burns. AGLE-102™ is an investigational product made up of native extracellular vesicles, which are […]
Provectus Biopharmaceuticals Establishes Research Collaboration with University of Nevada, Las Vegas to Investigate Small Molecule Immunotherapy Rose Bengal for Tissue Regeneration and Repair
KNOXVILLE, TN, July 19, 2022 (GLOBE NEWSWIRE) — Provectus (OTCQB: PVCT) today announced that the Company has initiated a new sponsored research program with Kelly Tseng, PhD, Associate Professor of Pathology and Lab Medicine, School of Life Sciences at the University of Nevada, Las Vegas (UNLV) to characterize the effects of Provectus’ pharmaceutical-grade rose bengal […]